Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a Pennsylvania-based leader in the medical technology industry, recently announced that it has granted restricted stock units (RSUs) covering 5,500 shares of …
TELA Bio’s Strategic Move: Offering Restricted Stock Units to New Hires Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, recently announced the approval of inducement grants for its newly-hired employees. The Compensation Committee of TELA Bio’s …
TELA Bio Grants Restricted Stock Units to New Employees as Part of Compensation Package Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a Pennsylvania-based medical technology company, recently announced its participation in the Connecting the Dots series. This collection of branded films is presented …
TELA Bio Features in MedTech Europe’s Film Series, Showcasing OviTex Reinforced Tissue Matrix in Hernia Repair Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a frontrunner in the medical technology industry, has announced its participation in Piper Sandler’s 35th Annual Healthcare Conference. The commercial-stage company is …
TELA Bio to Showcase Innovations at Piper Sandler’s 35th Annual Healthcare Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, has recently announced the approval of inducement grants by its Compensation Committee. The grants, which cover 40,700 …
TELA Bio Announces Inducement Grants for Newly-Hired Employees Under Nasdaq Rule Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …
TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More